Endo, Inc

PhaseBio Pharmaceuticals, located in Malvern, PA, is dedicated to developing innovative therapies for cardiovascular diseases, which currently affect one in four individuals. The company aims to address the pressing need for new treatment options by leveraging high-quality science and the expertise of its team to create a unique pipeline of medicines. Committed to improving patient outcomes and enhancing the healthcare system, PhaseBio focuses on overcoming the challenges associated with serious cardiovascular conditions. Their mission underscores a determination to deliver specialized therapies that can provide superior results for patients in need. Generated from the website

Baudax Bio, Inc. is a biotechnology company based in Malvern, PA, dedicated to developing and commercializing innovative products for rare and autoimmune diseases. With a commitment to providing meaningful therapeutic options, their pipeline includes clinical and early-stage product candidates, including the recently acquired TCR TReg platform and two novel neuromuscular blocking agents and a related proprietary chemical reversal agent. Driven by a mission to bring hope to patients, healthcare providers, and payers, Baudax Bio focuses on addressing unmet medical needs in the field of rare and autoimmune diseases. Through their innovative portfolio pipeline, they aim to make a significant impact in improving the lives of those affected by these conditions.Generated from the website

Annovis Bio, Inc is a biopharmaceutical company based in Berwyn, PA, dedicated to developing transformative therapies for neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Their innovative approach focuses on reducing neurotoxic proteins and improving axonal transport to enhance the flow of information along nerve cells, offering new hope in addressing the largest unmet need of an aging population. With a pipeline of drugs in development, Annovis Bio aims to reverse the toxic cascade that leads to nerve cell death by targeting impaired axonal transport caused by high levels of neurotoxic proteins. By tackling the root causes of neurodegeneration, including plaques, tangles, and Lewy bodies, the company strives to provide effective treatments for these debilitating conditions.Generated from the website